Search - tctmd.com

Displaying 261 - 275 of 275

Sort: Relevancy | Date

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Daily News

EES Show Long-term Safety Advantage over SES

L.A. McKeown

May 24, 2011

News Daily News

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

May 16, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

News Conference News

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Caitlin E. Cox

February 15, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

News Daily News

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Caitlin E. Cox

January 04, 2011

CME

Updates on Onyx ONE

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

What’s Next for Left Main PCI?

CME

Latest Data on Left Main Stenting and its Implications

CME

Advertisement

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

EES Show Long-term Safety Advantage over SES

Long-term Safety of PCI vs. CABG for Left Main Disease Depends on Syntax Score

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

SYNTAX Left Main: PCI Provides Similar Angina Relief to CABG at Lower Cost

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Final Kissing Balloon Unnecessary in Single-Stent Approach to Bifurcation Lesions

Updates on Onyx ONE

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

What’s Next for Left Main PCI?

Latest Data on Left Main Stenting and its Implications

Key Design Criteria For True Next Generation DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content